Berivan Bıtık

649 citations
37 papers · 468 indexed · h-index 12

Berivan Bıtık

33 papers receiving 456 citations

Peers

Berivan Bıtık
Comparison fields: 5 of 71
  • Rheumatology 195
  • Orthopedics and Sports Medicine 68
  • Hematology 70
  • Nephrology 37
  • Ophthalmology 39
Replace Cemal Beş with:
Cemal Beş Türkiye
Yunus Ugan Türkiye
Richard M. van Vugt Netherlands
Florentin Ananu Vreju Romania
A Ehling Germany
In Ah Choi South Korea
J. Ivorra Cortés Spain
Y Pawlotsky France
M. Fernández Castro Spain
Berivan Bıtık relative to Cemal Beş Türkiye Cemal Beş's profile →
Citations per field
00.5×3.9×
Cemal Beş · 1×
Citations per year

Countries citing papers authored by Berivan Bıtık

Since Specialization
Citations

This map shows the geographic impact of Berivan Bıtık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berivan Bıtık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berivan Bıtık more than expected).

Fields of papers citing papers by Berivan Bıtık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berivan Bıtık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berivan Bıtık. The network helps show where Berivan Bıtık may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Berivan Bıtık, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Berivan Bıtık Line = papers co-authored together Berivan Bıtık links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20241
3 20231
4 20220
5 202010
6 20201
7 20202
8 20187
9 20173
10 20172
11 20151
12 201527
13 20148
14 20148
15 201324
16 201342
17 20130
18 201320
19 20092
20 200917

About Berivan Bıtık

Berivan Bıtık is a scholar working on Rheumatology, Ophthalmology, Nephrology, Pharmacology and Orthopedics and Sports Medicine, having authored 37 papers that have together received 468 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Ocular Diseases and Behçet’s Syndrome (7 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Inflammatory mediators and NSAID effects (5 papers), Sarcoidosis and Beryllium Toxicity Research (4 papers), Vasculitis and related conditions (4 papers), Gout, Hyperuricemia, Uric Acid (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). The work is most often cited by research in Rheumatology (195 citations), Orthopedics and Sports Medicine (68 citations), Hematology (70 citations), Nephrology (37 citations) and Ophthalmology (39 citations). Berivan Bıtık has collaborated with scholars based in Türkiye, United States and Cyprus. Frequent co-authors include Berna Göker, Şeminur Haznedaroğlu, Abdurrahman Tufan, Rıdvan Mercan, Mehmet Akif Öztürk, Nuh Ataş, Mehmet Engin Tezcan, Aynur Turan, Arif Kaya and Cem Nuri Aktekin. Their work appears in journals such as Annals of the Rheumatic Diseases, Pediatric Rheumatology, Osteoarthritis and Cartilage, Journal of Clinical Laboratory Analysis and Renal Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026